Decision-tree sensitivity analysis for cost-effectiveness of whole-body FDG PET in the management of patients with non-small-cell lung carcinoma in Japan.
about
A systematic review of PET and PET/CT in oncology: a way to personalize cancer treatment in a cost-effective manner?Discrete serum protein signatures discriminate between human retrovirus-associated hematologic and neurologic disease.Estimated cost savings from reducing errors in the preparation of sterile doses of medications.Is 18F FDG PET-CT cost effective in lung cancer?Assessing short-term effects and costs at an early stage of innovation: the use of positron emission tomography on radiotherapy treatment decision making.
P2860
Decision-tree sensitivity analysis for cost-effectiveness of whole-body FDG PET in the management of patients with non-small-cell lung carcinoma in Japan.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Decision-tree sensitivity anal ...... -cell lung carcinoma in Japan.
@en
Decision-tree sensitivity anal ...... -cell lung carcinoma in Japan.
@nl
type
label
Decision-tree sensitivity anal ...... -cell lung carcinoma in Japan.
@en
Decision-tree sensitivity anal ...... -cell lung carcinoma in Japan.
@nl
prefLabel
Decision-tree sensitivity anal ...... -cell lung carcinoma in Japan.
@en
Decision-tree sensitivity anal ...... -cell lung carcinoma in Japan.
@nl
P2093
P2860
P356
P1476
Decision-tree sensitivity anal ...... -cell lung carcinoma in Japan.
@en
P2093
Hideo Kobayashi
Kiyoshi Ichihara
Masazumi Watanabe
Shigeru Kosuda
Shoichi Kusano
P2860
P2888
P304
P356
10.1007/BF03000105
P577
2002-06-01T00:00:00Z